AnalystsFrank TakkinenFrank Takkinen's Stock Forecasts
AnalystsFrank Takkinen
Analyst Ranking
Bottom 3%
#5021 out of 5134 analysts
Average Return
-12.64%
Win Rate
36%26 out of 73
Risk vs Reward
Poor
Good
Frank Takkinen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuropace IncNPCE | +228.63% | $4.75 | $15.61 | 2023-02-22 - 2024-02-21 | Strong Buy |
Elutia IncELUT | +183.09% | $1.36 | $3.85 | 2023-09-28 - 2024-09-27 | Strong Buy |
Silk Road Medical IncSILK | +132.73% | $11.55 | $26.88 | 2024-01-03 - 2024-06-18 | Strong Buy |
Sight Sciences IncSGHT | +89.86% | $4.24 | $8.05 | 2025-08-08 - 2025-12-05 | Strong Buy |
Axogen IncAXGN | +82.28% | $18.28 | $33.32 | 2025-03-17 - 2025-12-05 | Strong Buy |
Frank Takkinen Analyst Color
Get additional color on Frank Takkinen's coverage of popular stocks
Frank Takkinen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Axogen IncAXGN | 2 | Strong Buy | $40.00 | +20.05% | Maintains | 4 days ago |
Inotiv IncNOTV | 8 | Strong Buy | $3.00 | +271.29% | Maintains | 4 days ago |
Adagio Medical Holdings IncADGM | 1 | Strong Buy | $4.00 | +331.97% | Initiates Coverage On | 6 days ago |
Tela Bio IncTELA | 3 | Strong Buy | $3.00 | +160.87% | Maintains | 7 days ago |
Pulmonx CorpLUNG | 3 | Strong Buy | $4.00 | +99.00% | Maintains | a month ago |
Sight Sciences IncSGHT | 6 | Strong Buy | $7.00 | -13.04% | Maintains | 2 months ago |
Avita Medical IncRCEL | 1 | Hold | $4.00 | +14.29% | Downgrades | 2 months ago |
Elutia IncELUT | 4 | Strong Buy | $6.00 | +764.55% | Maintains | 3 months ago |
Hyperfine IncHYPR | 2 | Strong Buy | $2.00 | +85.19% | Maintains | 4 months ago |
Inspire Medical Systems IncINSP | 2 | Strong Buy | $150.00 | +9.64% | Maintains | 4 months ago |
Angiodynamics IncANGO | 1 | Strong Buy | $24.00 | +78.17% | Initiates Coverage On | 5 months ago |
Beta Bionics IncBBNX | 1 | Strong Buy | $30.00 | +2.11% | Assumes | 6 months ago |
Cvrx IncCVRX | 7 | Strong Buy | $14.00 | +54.70% | Maintains | 8 months ago |
Lensar IncLNSR | 2 | Hold | $15.00 | +33.93% | Downgrades | 8 months ago |
Cellebrite DI LtdCLBT | 3 | Strong Buy | $26.00 | +42.23% | Maintains | 10 months ago |
Clearpoint Neuro IncCLPT | 4 | Strong Buy | $30.00 | +121.57% | Maintains | a year ago |
Koru Medical Systems IncKRMD | 2 | Strong Buy | $5.00 | -10.23% | Maintains | a year ago |
Anteris Technologies Global CorpAVR | 1 | Strong Buy | $20.00 | +328.27% | Initiates Coverage On | a year ago |
Inspiremd IncNSPR | 1 | Strong Buy | $5.00 | +165.96% | Initiates Coverage On | a year ago |
Artivion IncAORT | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Silk Road Medical IncSILK | 2 | Hold | $27.50 | N/A | Downgrades | a year ago |
Envoy Medical IncCOCH | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Stereotaxis IncSTXS | 2 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Neuropace IncNPCE | 2 | Strong Buy | $12.00 | N/A | Reiterates | 2 years ago |
Icad IncICAD | 3 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Apyx Medical CorpAPYX | 3 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Biolase IncBIOL | 2 | Strong Buy | $40.00 | N/A | Maintains | 3 years ago |
Edap Tms SaEDAP | 2 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Greenbrook Tms IncGBNHF | 1 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Pavmed IncPAVM | 2 | Strong Buy | $22.50 | N/A | Maintains | 3 years ago |
Apollo Endosurgery IncAPEN | 2 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Uphealth IncUPHL | 1 | Hold | $10.00 | N/A | Downgrades | 4 years ago |
Biotricity IncBTCY | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Science 37 Holdings IncSNCE | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 4 years ago |
Skylight Health Group IncSLHGF | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.